Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 11:16:57-73.
doi: 10.2147/TCRM.S214187. eCollection 2020.

Failure to Reach a Consensus in Polypharmacy Definition: An Obstacle to Measuring Risks and Impacts-Results of a Literature Review

Najwa Taghy  1 , Linda Cambon  2 , Jean-Marie Cohen  3 , Claude Dussart  4
Affiliations
Review

Failure to Reach a Consensus in Polypharmacy Definition: An Obstacle to Measuring Risks and Impacts-Results of a Literature Review

Najwa Taghy et al. Ther Clin Risk Manag. .

Abstract

Introduction: The risk of polypharmacy is on the rise in most industrialized countries, threatening to burden their health systems. Although many definitions exist and numerous concepts are found in literature as synonyms, the phenomenon of polypharmacy remains poorly defined. The aim of this literature review is to provide an overview of available definitions of polypharmacy, to analyse their convergences and divergences and to discuss the consequences on the assessment of the problem.

Methods: A literature review was conducted to identify all published systematic reviews on definitions of polypharmacy available via Scopus and Pubmed databases. The Assessment of Multiple Systematic Reviews (AMSTAR) tool was used to appraise the methodological quality of the selected reviews. Available definitions and other characteristics were extracted; summarised in a table and analysed.

Results: Six systematic reviews were identified. They were published between 2000 and 2018. Three focussed on definitions of polypharmacy in the elderly; two in the general population and one in children. The strategy adopted in reviews is more rigorous in the most recent ones. However, they remain, at best, partially exhaustive. The definitions found in the literature used two main approaches, either (i) quantitative, applying varying thresholds and types of polypharmacy based on the number of medications being taken by the patient (ii) qualitative, based on the clinical indications and effects of a given drug regimen, with a growing number of characteristics to describe polypharmacy. The term "inappropriate" is increasingly associated with polypharmacy especially in studies that aimed to use this definition to identify possible solutions for healthcare providers in the field related to aging.

Conclusion: This review confirms a high variability and an evolution in the approaches defining "polypharmacy" in the absence of a consensus following standardized criteria. That makes it very difficult to estimate and measure the outcomes associated with this phenomenon.

Keywords: definition; literature review; polypharmacy.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Flow chart for review of systematic reviews of polypharmacy definition.
See this image and copyright information in PMC

References

    1. WHO Centre for Health Development (Kobe J. A glossary of terms for community health care and services for older persons. 2004. [cité 8 janv 2020]; Disponible sur: https://apps.who.int/iris/handle/10665/68896.
    1. Pieper D, Mathes T, Eikermann M Can AMSTAR also be applied to systematic reviews of non-randomized studies? BMC Res Notes [Internet]. September 6, 2014. [cité janv 6, 2019];7 Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167129/. Accessed December12, 2019. - PMC - PubMed
    1. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE What is polypharmacy? A systematic review of definitions. BMC Geriatr [Internet] October 10, 2017. [cité juill 9, 2018];17 Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635569/. Accessed December12, 2019. - PMC - PubMed
    1. Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10. doi:10.1186/1471-2288-7-10 - DOI - PMC - PubMed
    1. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3(2):383–389. doi:10.2147/CIA.S2468 - DOI - PMC - PubMed

LinkOut - more resources